This stronger functional change could easily explain its more severe clinical consequences in patients with PASNA; this is further supported by the similar biophysical changes observed for the other PASNA mutation, G403D (23). This evidence concerns the gene CACNA1D and aldosterone-producing adenoma with seizures and neurological abnormalities.